Exclusive Access, Inclusive Growth


Exclusive Access, Inclusive Growth

Pharma + healthcare


The vaccine race: India should revisit its animal-testing rules to be Atmanirbhar in pandemic fight

For a country known for making affordable, quality medicines, India’s contribution to global efforts in developing a Covid-19 vaccine has been rather lacklustre. A dearth of human talent is not the challenge before the country. To lead the drug-development race, besides building quality infrastructure, India needs to allow testing on larger animals such as dogs and monkeys.


Ajay Piramal eyes next leg of growth, but the model of growing through buyouts has stiff competition

His broad plays — a global business of contract manufacturing; making critical-care medicines used in hospitals; and selling OTC drugs in India— all have the potential for significant scale, but they come with their share of challenges. Also, a re-entry in the domestic pharma formulations business won’t be as easy as popping a pill.

headset AUDIO SUMMARY . 01:31

Japan’s AnGes preps capacity for 1 million doses as vaccine development continues

The country hopes to counter any second wave of infections by building production capacity while vaccines are still in the works. AnGes is developing a DNA vaccine that will use genetic material from the coronavirus to stimulate the production of human antibodies against the disease. The vaccine is expected to begin clinical trials soon.

22 Jun 20203 comments

From opportunity to ordeal: how the contagion turned into a testing time for diagnostic labs

Over the past three months, private diagnostic labs have been grappling with shifting government protocols for coronavirus testing, logistical issues, and a sharp decline in non-Covid-19 business. The lockdown, manpower crunch, and increase in costs worsened the situation. However, a quick recovery is expected, as demand for testing is likely to remain firm while the lockdown eases.

Medical devices

From India to Italy and Mexico to Oman, is a common ally in the fight against pandemic

Mumbai-based’s AI-powered solution can identify 20 different abnormalities in a chest X-ray, including the Covid-19 infection. The tool reduces the need of a trained technician and processes results in a minute. For a country in need of an affordable and effective mass-screening product, this could be the way forward.

headset AUDIO SUMMARY . 01:35


[[/message]] [[#message]]